- Bedoelde u
- through infection
Zoekresultaten - 9 results
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.
J Transplant, Volume 23, Issue 5 (2023) Keywords: Antibodies, Neutralizing Antibodies, Viral BNT162 Vaccine Breakthrough Infections Cohort Studies COVID-19 Humans Immunoglobulin G Interferon-gamma Kidney ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Antibodies, Viral BNT162 Vaccine Breakthrough Infections COVID-19 COVID-19 Vaccines Humans Immunity nursing homes Population Groups RNA, Messenger SARS-CoV-2 Abstract: BACKGROUND: Nursing home residents, ...
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
cancer, especially hematological cancer, are at increased risk for breakthrough COVID-19 infection. So far, a predictive biomarker that can assess compromised vaccine-induced anti- SARS-CoV-2 immunity in ...
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.
infectiousness of breakthrough cases (VE i) for a complete schedule of Ad26. COV2.S, ChAdOx1, BNT162 b2, mRNA-1273 as well as infection-acquired and hybrid immunity. We used a multilevel Bayesian model and ...
Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium.
Abstract: The objective of this study was to investigate the incidence and risk factors associated with COVID-19 vaccine breakthrough infections. We included all persons ≥18 years that had been fully ...
Risk factors associated with breakthrough SARS-CoV-2 infections after vaccination: a prospective cohort study in Belgium
Publication Type: Scientific poster, presentation or proceeding Authors: Veerle Stouten; Pierre Hubin; Freek Haarhuis; Joris Van Loenhout; Matthieu Billuart; Ruben Brondeel; Toon Braeye; Herman Van Oyen; Chloé Wyndham-Thomas; Lucy Catteau Source: (2022) H ...
Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes.
responses to mRNA vaccination observed in infection naïve residents and in some naïve staff members of NH suggest suboptimal protection against breakthrough infection, especially with variants of concern. ...
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.
was delayed and diminished, mainly in patients receiving chemotherapy or rituximab, resulting in breakthrough infections. Health Topics: Health and disease monitoring Surveillance de la santé et des ...
Increasing risk of breakthrough COVID-19 in outbreaks with high attack rates in European long-term care facilities, July to October 2021
Eurosurveillance, Volume 26, Issue 49 (2021) Health Topics: Coronavirus Coronavirus Coronavirus Service: Infections liées aux soins et antibiorésistance Zorginfecties en antibioticaresistentie Healthcare-associated ...